Cytodyn Inc (CYDY)

[The Lawman]

I agree with Broker57: Pourhassan must go.

It is not merely that Pourhassan is not qualified to take PRO 140 to the finish line, and does not have the intellect or temperment to speak well on behalf of the company, but he is also grossly overpaid.

Pourhassan no doubt wants the company to succeed, as he holds a significant amounts of warrants. However, there is nothing in his background or experience which suggests he has the ability to make Cytodyn a successful company.

Moreover, if you have ever listened to any of the shareholder or analyst calls Pourhassan has hosted,or better yet, spoke to him personally, you would conclude he is the wrong man for the job as he is not well-spoken,gets angry when challenged, and does not present well.

This is not about bashing or pumping, but the reality of the situation we as shareholders face.PRO 140 has tremendous potential. However, the success of this company, like most, rests on the ability of management to direct the company properly.

Put PRO 140 in the hands of an executive who has a history of obtaining FDA approval of a clinical stage drug, and then getting the company sold to Big Pharma, and shareholder confidence would be restored, and the stock price would languish at around 70 cents.

I am very heavily invested in CYDY, and very much want it to succeed. However, I think the chances of success are greatly diminished by having an underqualified and overcompensated president at its helm.